Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Unaudited Financial results ....

Date: 28.07.2026 Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 524748 Dear Sir/Madam, Sub: Intimation of Board Meeting for approval of Unaudited Financial Results for the quarter ended June 30, 2026 & Closure of Trading Window. This is to inform that pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday,05th August, 2026, inter-alia to consider and approve the unaudited financial results of the Company for the quarter ended on June 30, 2026. Further, in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the trading window of the Company is already closed from 01st July, 2026 and will open 48 hours after the declaration of unaudited financial results for the quarter ended 30th June, 2026, intimation of which has already been provided to BSE as on 26th June, 2026. Kindly take the same on record. Thanking you, Yours faithfully, For Link Pharma Chem Limited Komal Bhojwani Company Secretary & Compliance Officer Membership No.: A65594 REGISTERED OFFICE: Plot No. 162, G.I.D.C., Nandesari - 391340, Dist. Vadodara (Gujarat) (India) Tel. (O)9925057946 E-Mail: linkpharmacs@gmail.com CIN: L24230GJ1984PLC007540 Website: www.linkpharmachem.co.in